Sagespring Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Sagespring Wealth Partners's LLY Position: Q1 2026 in Review
Sagespring Wealth Partners increased its Eli Lilly (LLY) stake by 4.8% in Q1 2026, buying an estimated $478K and bringing the position to 10,324 shares worth $9.5M. The position accounts for 0.17% of the portfolio, ranked #74.
Sagespring Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.6M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sagespring Wealth Partners held 10,324 shares of Eli Lilly worth $9.5M as of Q1 2026.
- Sagespring Wealth Partners bought 471 Eli Lilly shares in Q1 2026, an estimated $478K.
- Eli Lilly made up 0.17% of Sagespring Wealth Partners's portfolio in Q1 2026, its #74 holding.
- Sagespring Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Sagespring Wealth Partners's Eli Lilly position peaked at $10.6M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.